ACHC
Acadia Healthcare Company, Inc.
$24.60
-1.17%
$2.3B
No data for this timeframe.
Vol
Market Cap$2.3B
Cap SizeMid Cap
Analyst ConsensusBuy (60%)
Inst. Holders50 funds
Inst. Value$1.8B
Inst. Activity25 buys / 10 sells
SEC Reports6
Exchange Nasdaq·Sector Services-Specialty Outpatient Facilities, NEC·Inc. DE·CIK 0001520697·Prev Close $24.89
Recent Activity
Jun 10, 2026
short_volume
Short Volume: ACHC — 70.5% short (0.4M / 0.6M)
Short: 442,513 | Exempt: 100 | TRF Vol: 627,389 | Short Ratio: 70.5% | Off-exchange volume (dark poo
May 27, 2026
SEC
The Georgia Court of Appeals dismissed an appeal against Acadia Healthcare because the appellant failed to file a timely
COURT-RULING — Impact 2/10
May 27, 2026
Event
NATALIE NAYLOR-LOWE, AS ADMINISTRATOR OF THE ESTATE OF BASIL NAYLOR v. ACADIA HEALTHCARE COMPANY, INC.
Court ruling from Court of Appeals of Georgia. Docket: A26A1699
May 18, 2026
SEC
Acadia Healthcare disclosed that a California jury awarded $105 million ($35 million compensatory + $70 million punitive
8-K — Impact 7/10
May 6, 2026
Insider
GRIECO WILLIAM was granted 6,331 shares
Director
May 6, 2026
Insider
KELLY RALPH DAVID was granted 6,331 shares
Director
May 6, 2026
Insider
Bissell E. Perot was granted 6,331 shares
Director
Apr 29, 2026
SEC
Acadia Healthcare reported Q1 2026 adjusted EPS of $0.37, beating consensus of $0.28 by 32%, and revenue of $828.8M (+7.
8-K — Impact 8/10
Price Targets
$28.86
+17.3% upside
Buy
Current $24.60
Low $13.00
Median $30.00
High $39.00
14 analysts
$13.00
$39.00
Analyst Ratings
4Strong Buy
8Buy
7Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 3, 2026 | Jefferies | UPGRADE | Hold → Buy |
| May 4, 2026 | RBC Capital | MAINTAIN | Outperform → Outperform |
| May 4, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| May 1, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral → Neutral |
| May 1, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.36 ▼ -5.8% | $0.32 — $0.57 | -56% YoY | 13 |
| Next Q | $0.48 | $0.43 — $0.56 | -33% YoY | 13 |
| Current FY | $1.51 | $1.46 — $1.66 | -25% YoY | 13 |
| Next FY | $1.75 | $1.60 — $1.90 | 16% YoY | 13 |
Latest Reports
NEUTRAL
COURT-RULING
2/10
The Georgia Court of Appeals dismissed an appeal against Acadia Healthcare because the appellant failed to file a timely
May 27, 2026
BEARISH
8-K
7/10
Acadia Healthcare disclosed that a California jury awarded $105 million ($35 million compensatory + $70 million punitive
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $273.3M | — |
| WELLINGTON MANAGEMENT GROUP LLP | $212.2M | — |
| FMR LLC | $160.6M | ADD |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $118.4M | — |
| MORGAN STANLEY | $105.0M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 6, 2026 | GRIECO WILLIAM | A | $0.00 |
| May 6, 2026 | KELLY RALPH | A | $0.00 |
| May 6, 2026 | Bissell E. | A | $0.00 |
| May 6, 2026 | Gregg Vicky | A | $0.00 |
| May 6, 2026 | Bernhard Jason | A | $0.00 |
50 institutional holders with $1.8B total value (78,747,444 shares) as of 2026-Q1. Top holders: BlackRock,, WELLINGTON, FMR. Net buying activity: 25 institutions added/increased vs 10 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11,686,389 | $273.3M | 14.9% | — |
| 2 | WELLINGTON MANAGEMENT GROUP LLP | 9,072,942 | $212.2M | 11.5% | — |
| 3 | FMR LLC | 6,867,678 | $160.6M | 8.7% | ADD +26.8% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5,061,438 | $118.4M | 6.4% | — |
| 5 | MORGAN STANLEY | 4,491,067 | $105.0M | 5.7% | DOUBLED +193.8% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4,154,801 | $97.2M | 5.3% | — |
| 7 | STATE STREET CORP | 3,218,751 | $75.3M | 4.1% | — |
| 8 | CITADEL ADVISORS LLC | 2,716,425 | $63.5M | 3.5% | — |
| 9 | DIMENSIONAL FUND ADVISORS LP | 2,581,747 | $60.4M | 3.3% | — |
| 10 | CITIGROUP INC | 2,352,318 | $55.0M | 3.0% | — |
| 11 | GOLDMAN SACHS GROUP INC | 2,240,428 | $52.4M | 2.8% | — |
| 12 | Neuberger Berman Group LLC | 1,961,384 | $45.8M | 2.5% | ADD +72.4% |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,900,947 | $44.5M | 2.4% | ADD +33.5% |
| 14 | VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | 1,839,125 | $43.0M | 2.3% | NEW |
| 15 | FARALLON CAPITAL MANAGEMENT LLC | 1,736,800 | $40.6M | 2.2% | NEW |
| 16 | FIRST TRUST ADVISORS LP | 1,689,442 | $39.5M | 2.1% | ADD +73.0% |
| 17 | BANK OF AMERICA CORP /DE/ | 1,231,172 | $28.8M | 1.6% | ADD +64.7% |
| 18 | DEUTSCHE BANK AG\ | 1,158,860 | $27.1M | 1.5% | ADD +35.1% |
| 19 | Allianz Asset Management GmbH | 890,278 | $20.8M | 1.1% | DOUBLED +129.4% |
| 20 | Rubric Capital Management LP | 850,000 | $19.9M | 1.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 5,418,088 | 6,867,678 | +26.8% | $160.6M | 2026-Q1 |
| MORGAN STANLEY | DOUBLED | 1,528,476 | 4,491,067 | +193.8% | $105.0M | 2026-Q1 |
| Neuberger Berman Group LLC | ADD | 1,137,602 | 1,961,384 | +72.4% | $45.8M | 2026-Q1 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 1,423,720 | 1,900,947 | +33.5% | $44.5M | 2026-Q1 |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | NEW | — | 1,839,125 | — | $43.0M | 2026-Q1 |
| FARALLON CAPITAL MANAGEMENT LLC | NEW | — | 1,736,800 | — | $40.6M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | ADD | 976,590 | 1,689,442 | +73.0% | $39.5M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 747,523 | 1,231,172 | +64.7% | $28.8M | 2026-Q1 |
| DEUTSCHE BANK AG\ | ADD | 857,943 | 1,158,860 | +35.1% | $27.1M | 2026-Q1 |
| Allianz Asset Management GmbH | DOUBLED | 388,150 | 890,278 | +129.4% | $20.8M | 2026-Q1 |
| Freestone Grove Partners LP | NEW | — | 636,116 | — | $14.9M | 2026-Q1 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | NEW | — | 575,243 | — | $13.5M | 2026-Q1 |
| Point72 Asset Management, L.P. | NEW | — | 536,517 | — | $12.5M | 2026-Q1 |
| STRS OHIO | DOUBLED | 2,180 | 347,637 | +15846.7% | $8.1M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 227,557 | 316,398 | +39.0% | $7.4M | 2026-Q1 |
| CONGRESS ASSET MANAGEMENT CO | ADD | 137,809 | 236,097 | +71.3% | $5.5M | 2026-Q1 |
| Trexquant Investment LP | NEAR_EXIT | 824,089 | 159,682 | -80.6% | $3.7M | 2026-Q1 |
| MARSHALL WACE, LLP | TRIM | 470,393 | 149,196 | -68.3% | $3.5M | 2026-Q1 |
| Holocene Advisors, LP | DOUBLED | 58,513 | 130,564 | +123.1% | $3.1M | 2026-Q1 |
| TORONTO DOMINION BANK | TRIM | 414,400 | 129,553 | -68.7% | $3.0M | 2026-Q1 |
| FRANKLIN RESOURCES INC | ADD | 82,561 | 110,269 | +33.6% | $2.6M | 2026-Q1 |
| STATE OF WISCONSIN INVESTMENT BOARD | TRIM | 66,617 | 47,195 | -29.2% | $1.1M | 2026-Q1 |
| Jain Global LLC | TRIM | 131,202 | 44,038 | -66.4% | $1.0M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | NEAR_EXIT | 200,200 | 30,195 | -84.9% | $706.3K | 2026-Q1 |
| Rockefeller Capital Management L.P. | TRIM | 70,368 | 28,138 | -60.0% | $658.1K | 2026-Q1 |
11 unique insiders with 15 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 6, 2026 | GRIECO WILLIAM | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | KELLY RALPH DAVID | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Bissell E. Perot | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Gregg Vicky B | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Bernhard Jason | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Cancelmi Daniel J | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Harris Patrice A | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | WAUD REEVE B | Director | AWARD | 6,331 | — | — |
| May 6, 2026 | Fucci Michael | Director | AWARD | 6,331 | — | — |
| May 5, 2026 | Farley Brian | EVP, CLAO and Secretary | TAX W/H | 5,063 | $27.69 | $140.2K |
| Apr 28, 2026 | Farley Brian | EVP, CLAO and Secretary | AWARD | 37,510 | — | — |
| Apr 10, 2026 | YOUNG TODD S. | Chief Financial Officer | AWARD | 58,799 | — | — |
| Apr 10, 2026 | Farley Brian | EVP, GC and Secretary | AWARD | 37,510 | — | — |
| Mar 12, 2026 | Cancelmi Daniel J | Director | AWARD | 6,625 | — | — |
| Feb 27, 2026 | Farley Brian | EVP, GC and Secretary | TAX W/H | 1,915 | $22.29 | $42.7K |
6 SEC filing reports analyzed. Sentiment: 1 bullish, 3 bearish, 0 mixed, 2 neutral. Avg impact: 5.8/10.
NEUTRAL
COURT-RULING
2/10
The Georgia Court of Appeals dismissed an appeal against Acadia Healthcare because the appellant fai
May 27, 2026
BEARISH
8-K
7/10
Acadia Healthcare disclosed that a California jury awarded $105 million ($35 million compensatory +
May 18, 2026
BULLISH
8-K
8/10
Acadia Healthcare reported Q1 2026 adjusted EPS of $0.37, beating consensus of $0.28 by 32%, and rev
Apr 29, 2026
BEARISH
COURT-RULING
7/10
The California Court of Appeal affirmed a $9 million jury verdict against Acadia Healthcare (ACHC) i
Apr 7, 2026
NEUTRAL
DEFA14A
3/10
Acadia Healthcare Company, Inc. (ACHC) has filed a Definitive Proxy Statement (DEFA14A) with the SEC
Mar 25, 2026
BEARISH
8-K
8/10
Acadia Healthcare reported a significant net loss of $12.16 per share for 2025 due to a $996.2 milli
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (60% buy). Based on 20 analysts: 4 strong buy, 8 buy, 7 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$28.86 mean target
+17.3% upside
Buy (2.00)
$13.00 Low
$39.00 High
| Metric | Value |
|---|---|
| Current Price | $24.60 |
| Target Low | $13.00 |
| Target Mean | $28.86 |
| Target Median | $30.00 |
| Target High | $39.00 |
| # Analysts | 14 |
| Recommendation | Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.36 | $0.32 | $0.57 | -56.5% | -5.8% | 1↑ 3↓ | $0.8B | -2.7% | 13 |
| Next Q 2026-09-30 |
$0.48 | $0.43 | $0.56 | -33.2% | -0.3% | 1↑ 3↓ | $0.9B | 3.3% | 13 |
| Current FY 2026-12-31 |
$1.51 | $1.46 | $1.66 | -24.6% | +0.3% | 2↑ 1↓ | $3.4B | 2.9% | 13 |
| Next FY 2027-12-31 |
$1.75 | $1.60 | $1.90 | 16.0% | +0.3% | 2↑ 1↓ | $3.6B | 6.0% | 13 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.361 | |
| 7d ago | $0.370 | -0.008 |
| 30d ago | $0.384 | -0.022 |
| 60d ago | $0.462 | -0.100 |
| 90d ago | $0.462 | -0.100 |
9 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 3, 2026 | Jefferies | UPGRADE | Hold | Buy |
| May 4, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| May 4, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| May 1, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral | Neutral |
| May 1, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 28, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Apr 17, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 3, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Leerink Partners | MAINTAIN | Market Perform | Market Perform |
| Feb 26, 2026 | UBS | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Feb 23, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Jan 22, 2026 | Jefferies | DOWNGRADE | Buy | Hold |
| Jan 16, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Jan 14, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Dec 18, 2025 | Mizuho | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 7 | 1 | 0 | 60% | |
| May 1, 2026 | 3 | 9 | 7 | 1 | 0 | 60% | |
| Apr 1, 2026 | 3 | 9 | 7 | 1 | 0 | 60% | |
| Mar 1, 2026 | 3 | 9 | 7 | 1 | 0 | 60% | |
| Feb 1, 2026 | 3 | 9 | 7 | 1 | 0 | 60% | |
| Jan 1, 2026 | 4 | 9 | 6 | 1 | 0 | 65% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 10, 2026
short_volume
Short Volume: ACHC — 70.5% short (0.4M / 0.6M)
Short: 442,513 | Exempt: 100 | TRF Vol: 627,389 | Short Ratio: 70.5% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: ACHC — 66.0% short (0.4M / 0.6M)
Short: 402,430 | Exempt: 0 | TRF Vol: 609,654 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: ACHC — 68.2% short (0.5M / 0.7M)
Short: 480,341 | Exempt: 26 | TRF Vol: 704,751 | Short Ratio: 68.2% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: ACHC — 61.2% short (0.4M / 0.6M)
Short: 350,371 | Exempt: 0 | TRF Vol: 572,718 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: ACHC — 67.7% short (0.4M / 0.5M)
Short: 360,369 | Exempt: 2,000 | TRF Vol: 532,002 | Short Ratio: 67.7% | Off-exchange volume (dark pool + OTC)
May 27, 2026
Enforcement
NATALIE NAYLOR-LOWE, AS ADMINISTRATOR OF THE ESTATE OF BASIL NAYLOR v. ACADIA HEALTHCARE COMPANY, INC.
Court ruling from Court of Appeals of Georgia. Docket: A26A1699
May 26, 2026
short_volume
Short Volume: ACHC — 59.7% short (0.4M / 0.7M)
Short: 406,827 | Exempt: 1,912 | TRF Vol: 681,987 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: ACHC — 61.4% short (0.5M / 0.8M)
Short: 479,632 | Exempt: 0 | TRF Vol: 780,693 | Short Ratio: 61.4% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: ACHC — 72.1% short (0.4M / 0.6M)
Short: 404,209 | Exempt: 226 | TRF Vol: 560,783 | Short Ratio: 72.1% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: ACHC — 2.8M shares, 46,565 trades
Week starting 2026-05-18. Total ATS volume: 2,753,834 shares across 46,565 trades.
May 14, 2026
short_volume
Short Volume: ACHC — 74.8% short (0.4M / 0.5M)
Short: 397,422 | Exempt: 0 | TRF Vol: 531,164 | Short Ratio: 74.8% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: ACHC — 70.6% short (0.9M / 1.3M)
Short: 943,661 | Exempt: 0 | TRF Vol: 1,337,462 | Short Ratio: 70.6% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: ACHC — 66.3% short (0.5M / 0.8M)
Short: 505,960 | Exempt: 2,797 | TRF Vol: 763,022 | Short Ratio: 66.3% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: ACHC — 2.8M shares, 51,722 trades
Week starting 2026-05-11. Total ATS volume: 2,775,078 shares across 51,722 trades.
May 6, 2026
short_volume
Short Volume: ACHC — 58.2% short (0.5M / 0.8M)
Short: 493,951 | Exempt: 0 | TRF Vol: 848,095 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_volume
Short Volume: ACHC — 55.2% short (0.7M / 1.2M)
Short: 659,229 | Exempt: 300 | TRF Vol: 1,195,326 | Short Ratio: 55.2% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
Enforcement
Sandoval v. Acadia Healthcare Co. CA1/1
Court ruling from California Court of Appeal. Docket: A168461